Abstract：OBJECTIVE: The efficacy of pulmonary surfactant (PS) replacement therapy for meconium aspiration syndrome (MAS) remains controversial. This study aimed to evaluate the efficacy of PS therapy in neonates with MAS by a meta-analysis. METHODS: Randomized controlled trials (RCTs) on the treatment of MAS with PS were searched electronically in medical debases including PubMed, Science Citation Index, The Cochrane Central Register of Controlled Trials, Ovid, EBSCOhost, BIOSIS previews, Chinese BioMedical Literature Database, Wanfang Database and VIP Chinese Sci-Tech Periodical Database. The Cochrane Handbook 5.0.2 was employed to evaluate methodological quality. RevMan 5.0.25 software was used for the meta-analysis. RESULTS: Eight RCTs including 512 MAS neonates (257 cases in the PS treatment group and 255 cases in the control group) were enrolled in this meta-analysis. The meta-analysis showed that PS treatment reduced oxygenation index (MD=-2.59; 95%CI: -4.33, -0.86; P=0.003), increased arterial oxygen/alveolar oxygen ratio (MD=0.05; 95%CI: 0.05, 0.06; P<0.00001), shortened hospitalization days (MD=-4.94; 95%CI: -7.44, -2.44; P=0.0001) and decreased mortality rate (OR=0.47; 95%CI: 0.24, 0.93; P=0.03) significantly. There were no statistical differences in the durations of mechanical ventilation and oxygen therapy, and the incidences of air leak, pulmonary hemorrhage and intracranial hemorrhage between the PS treatment and control groups. CONCLUSIONS: Currently published evidence from RCTs suggests that PS replacement therapy is effective for MAS, however because of the limited quantity and quality of trials enrolled in the study, further evidence from RCTs is needed to prove the efficacy.
LUO Fei-Fei,YANG Di-Yuan,CHEN Pan et al. Efficacy of pulmonary surfactant therapy in neonates with meconium aspiration syndrome: a meta-analysis[J]. CJCP, 2012, 14(06): 413-417.
［1］Qian L, Liu C, Zhuang W, Guo Y, Yu J, Chen H, et al. Neonatal respiratory failure: a 12-month clinical epidemiologic study from 2004 to 2005 in China ［J］. Pediatrics, 2008, 121 (5): e1115-e1124.
［2］Bhat RY, Rao A. Meconium-stained amniotic fluid and meconium aspiration syndrome: a prospective study［J］. Ann Trop Paediatr, 2008, 28(3): 199-203.
［4］El Shahed AI, Dargaville P, Ohlsson A, Soll R. Surfactant for meconium aspiration syndrome in full term/near term infants［J/OL］. Cochrane Database Syst Rev, 2007, (3): CD002054.
［11］Higgins JPT, Green S(editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 ［DB/OL］. The Cochrane Collaboration, 2009.［updated March 2011］. http://www.cochrane-handbook.org.
［12］Chinese Collaborative Study Group for Neonatal Respiratory Diseases (Sun Bo). Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicentre, randomized, controlled trial［J］. Acta Pediatrica, 2005, 94(7): 896-902.
［13］Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H,Walsh WF, et al. A multicenter, randomized, controlled trial comparing surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome［J］. Pediatrics, 2002, 109(6): 1081-1087.
［14］Dargaville PA, Copnell B, Mills JF, Haron I, Lee JK, Tingay DG, et al. Randomized controlled trial of lung lavage with dilute surfactant for meconium aspiration syndrome［J］. J Pediatr, 2010, 158(3): 383-389.
［15］Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure［J］. J Paediatr, 1998, 132(1): 40-47.
［16］Maturana A, Torres-Pereyra J, Salinas R, Astudillo P, Moya FR. A randomized trial of natural surfactant for moderate to severe meconium aspiration syndrome［J/OL］. PAS， 2005, 57: 1545.
［18］Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants［J］. Cochrane Database Syst Rev, 2001(2): CD000510.
［19］Sweet DG, Halliday HL. The use of surfactants in 2009［J］. Arch Dis Child Educ Pract Ed, 2009, 94(3): 78-83.
